Cargando…

Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route

BACKGROUND: Control of Tuberculosis (TB) infection is mainly the result of productive teamwork between T-cell populations and antigen presenting cells (APCs). However, APCs activation at the site of initiating cellular immune response during BCG early infection is not completely understood. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhengzhong, Li, Xin, Xia, Aihong, Zhang, Zhifang, Wan, Jiaxu, Gao, Yan, Meng, Chuang, Chen, Xiang, Jiao, Xin-an
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683112/
https://www.ncbi.nlm.nih.gov/pubmed/38012553
http://dx.doi.org/10.1186/s12865-023-00589-6
_version_ 1785151120292708352
author Xu, Zhengzhong
Li, Xin
Xia, Aihong
Zhang, Zhifang
Wan, Jiaxu
Gao, Yan
Meng, Chuang
Chen, Xiang
Jiao, Xin-an
author_facet Xu, Zhengzhong
Li, Xin
Xia, Aihong
Zhang, Zhifang
Wan, Jiaxu
Gao, Yan
Meng, Chuang
Chen, Xiang
Jiao, Xin-an
author_sort Xu, Zhengzhong
collection PubMed
description BACKGROUND: Control of Tuberculosis (TB) infection is mainly the result of productive teamwork between T-cell populations and antigen presenting cells (APCs). However, APCs activation at the site of initiating cellular immune response during BCG early infection is not completely understood. METHODS: In this study, we injected C57BL/6 mice in intravenous (i.v) or subcutaneous (s.c) route, then splenic or inguinal lymph node (LN) DCs and MΦs were sorted, and mycobacteria uptake, cytokine production, antigen presentation activity, and cell phenotype were investigated and compared, respectively. RESULTS: Ag85A-specific T-cell immune response began at 6 days post BCG infection, when BCG was delivered in s.c route, Th17 immune response could be induced in inguinal LN. BCG could induce high level of activation phenotype in inguinal LN MΦs, while the MHC II presentation of mycobacteria-derived peptides by DCs was more efficient than MΦs. CONCLUSIONS: The results showed that BCG immunized route can decide the main tissue of T-cell immune response. Compared with s.c injected route, APCs undergo more rapid cell activation in spleen post BCG i.v infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12865-023-00589-6.
format Online
Article
Text
id pubmed-10683112
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106831122023-11-30 Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route Xu, Zhengzhong Li, Xin Xia, Aihong Zhang, Zhifang Wan, Jiaxu Gao, Yan Meng, Chuang Chen, Xiang Jiao, Xin-an BMC Immunol Research BACKGROUND: Control of Tuberculosis (TB) infection is mainly the result of productive teamwork between T-cell populations and antigen presenting cells (APCs). However, APCs activation at the site of initiating cellular immune response during BCG early infection is not completely understood. METHODS: In this study, we injected C57BL/6 mice in intravenous (i.v) or subcutaneous (s.c) route, then splenic or inguinal lymph node (LN) DCs and MΦs were sorted, and mycobacteria uptake, cytokine production, antigen presentation activity, and cell phenotype were investigated and compared, respectively. RESULTS: Ag85A-specific T-cell immune response began at 6 days post BCG infection, when BCG was delivered in s.c route, Th17 immune response could be induced in inguinal LN. BCG could induce high level of activation phenotype in inguinal LN MΦs, while the MHC II presentation of mycobacteria-derived peptides by DCs was more efficient than MΦs. CONCLUSIONS: The results showed that BCG immunized route can decide the main tissue of T-cell immune response. Compared with s.c injected route, APCs undergo more rapid cell activation in spleen post BCG i.v infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12865-023-00589-6. BioMed Central 2023-11-27 /pmc/articles/PMC10683112/ /pubmed/38012553 http://dx.doi.org/10.1186/s12865-023-00589-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xu, Zhengzhong
Li, Xin
Xia, Aihong
Zhang, Zhifang
Wan, Jiaxu
Gao, Yan
Meng, Chuang
Chen, Xiang
Jiao, Xin-an
Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route
title Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route
title_full Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route
title_fullStr Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route
title_full_unstemmed Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route
title_short Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route
title_sort activation dynamics of antigen presenting cells in vivo against mycobacterium bovis bcg in different immunized route
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683112/
https://www.ncbi.nlm.nih.gov/pubmed/38012553
http://dx.doi.org/10.1186/s12865-023-00589-6
work_keys_str_mv AT xuzhengzhong activationdynamicsofantigenpresentingcellsinvivoagainstmycobacteriumbovisbcgindifferentimmunizedroute
AT lixin activationdynamicsofantigenpresentingcellsinvivoagainstmycobacteriumbovisbcgindifferentimmunizedroute
AT xiaaihong activationdynamicsofantigenpresentingcellsinvivoagainstmycobacteriumbovisbcgindifferentimmunizedroute
AT zhangzhifang activationdynamicsofantigenpresentingcellsinvivoagainstmycobacteriumbovisbcgindifferentimmunizedroute
AT wanjiaxu activationdynamicsofantigenpresentingcellsinvivoagainstmycobacteriumbovisbcgindifferentimmunizedroute
AT gaoyan activationdynamicsofantigenpresentingcellsinvivoagainstmycobacteriumbovisbcgindifferentimmunizedroute
AT mengchuang activationdynamicsofantigenpresentingcellsinvivoagainstmycobacteriumbovisbcgindifferentimmunizedroute
AT chenxiang activationdynamicsofantigenpresentingcellsinvivoagainstmycobacteriumbovisbcgindifferentimmunizedroute
AT jiaoxinan activationdynamicsofantigenpresentingcellsinvivoagainstmycobacteriumbovisbcgindifferentimmunizedroute